For the Inventor, By the Inventor

Enter assignee name

Roseville, MN, United States of America

Rebiotix, Inc.

USPTO Granted Patents = 34

EPO Patents = 4

Trademarks = 4

Forward Citations = 362

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Lee A Jones (28 out of 29 patents)

Courtney R Jones (28 out of 28 patents)

Edwin J Hlavka (22 out of 84 patents)

4. Ryan D Gordon (16 out of 17 patents)

5. Beth Anne-Szkudlarek Brown (10 out of 14 patents)

6. Joshua Erickson (10 out of 13 patents)

7. Messac Che Neba (3 out of 3 patents)

8. Mary Kay Sobcinski (2 out of 2 patents)

Core Competencies:

Microbiota Restoration Therapy

Bacteriotherapy

Clostridium Difficile

Compositions

Methods of Manufacture

Therapeutic Applications

MRT

Colitis Treatment

Therapeutic Composition

Restoration Techniques

Bacterial Therapy

34 patents: Sort by Forward Citations

1. 12102655 - Bacteriotherapy for clostridium difficile colitis (2024-10-01),

2. 12083150 - Microbiota restoration therapy (MRT), composition and methods of manufacture (2024-09-10),

3. 12036250 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2024-07-16),

4. 11986500 - Bacteriotherapy for clostridium difficile colitis (2024-05-21),

5. 11944654 - Bacteriotherapy for clostridium difficile colitis (2024-04-02),

6. 11654164 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2023-05-23),

7. 11642381 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2023-05-09),

8. 11554143 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2023-01-17),

9. 11446337 - Bacteriotherapy for clostridium difficile colitis (2022-09-20),

10. 10905726 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2021-02-02),

11. 10828340 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2020-11-10),

12. 10799539 - Microbiota restoration therapy (MRT) compositions and methods of manufacture (2020-10-13),

13. 10688137 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2020-06-23),

14. 10624932 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2020-04-21),

15. 10610547 - Microbiota restoration therapy (MRT), compositions and methods of manufacture (2020-04-07),

Company Overview

Rebiotix, Inc., based in Roseville, Minnesota, is a biotechnology company focused on developing innovative microbiome-based therapies. The company specializes in the research and manufacture of treatments aimed at restoring the balance of gut microbiota, particularly for patients suffering from recurrent Clostridium difficile infections. Rebiotix leverages advanced scientific methodologies to explore the therapeutic potential of the microbiome, contributing to the evolving landscape of personalized medicine and gastrointestinal health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

34 Patents

#6 in Roseville, MN

#284 in Minnesota

#10,002 in US

#19,612 in the World

Roseville, MN, United States of America

Rebiotix, Inc.

Forward Citations = 362

8 inventors:

Lee A Jones (28 out of 29 patents)

Courtney R Jones (28 out of 28 patents)

Edwin J Hlavka (22 out of 84 patents)

4. Ryan D Gordon (16 out of 17 patents)

5. Beth Anne-Szkudlarek Brown (10 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rebiotix, Inc.. Retrieved from https://idiyas.com/company/rebiotix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…